WHO Guidelines for the Treatment of Neisseria gonorrhoeae
. Geneva: WHO, 2016: 17-21.
Trends in antimicrobial resistance of Neisseria gonorrhoeae
isolated from Korean patients from 2000 to 2006.
Susceptibility of Neisseria gonorrhoeae
to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
Bala et al., "Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae
isolates from India, Pakistan and Bhutan in 2007-2011," BMC Infectious Diseases, vol.
(10) The use of ciprofloxacin 500 mg orally as an alternative to a 250 mg ceftriaxone injection for the treatment of Neisseria gonorrhoeae
infections has been made possible by the development of a rapid genotypic assay for the determination of mutation at codon 91 of the gyrase A (gyrA) gene of Neisseria gonorrhoeae
; a non-mutated (wild-type) gyrA genotype reliably predicts full susceptibility to ciprofloxacin.
Las recomendaciones de utilizar farmacos mas efectivos suelen ser motivo de preocupacion en cuanto al costo y al posible uso inadecuado, pues se observo que Neisseria gonorrhoeae
presento a lo largo del tiempo un incremento en la resistencia a los antibioticos usados para su tratamiento.
Comparison of Two Studies Comparison with other Study Percentage Type of infection Study by Bowring et al Present Study Neisseria gonorrhoeae
50% 72% Chlamydia trachomatis 12.50% 14% Co-infection of Neisseria 12.50% 14% gonorrhoeae and Chlamysia trachomatis Note: Table made from bar graph.
in order to have more and correct information about the prevalence of Neisseria gonorrhoeae
with using of phenotyping (culture) and genotyping (PCR) methods.
"The Entasis product is the only one specifically developed for Neisseria gonorrhoeae
" she said.
This report provides comprehensive information on the therapeutic development for Neisseria Gonorrhoeae
Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
This study characterises the Neisseria gonorrhoeae
culture collection strains available from Institute of Environmental Science and Research (ESR) in Kenepuru, New Zealand by three molecular assays designed to predict resistance or reduced susceptibility.
The topics include transmembrane molecular transporters facilitating export of molecules from cells and organelles, the machinery and mechanism of multi-drug efflux in Gram-negative bacteria, the role of efflux pumps in the nosocomial pathogens Staphylococcus aureus and Acinotobacter baumannii, Salmonella efflux pumps, and the function and regulation of Neisseria gonorrhoeae